Carcinoid tumours of the lung and definition of the medico-legal term "lung cancer" used in the list of occupational disease in Germany - Results of the German mesothelioma register;Erfüllen karzinoidtumoren der lunge die legaldefinition für den begriff "lungenkrebs" der berufskrankheitenverordnung? - Untersuchungsergebnisse des Deutschen mesotheliomregisters

Pneumologie

Volumn 62, Issue 9, 2008, Pages 569-573

  Neumann, V ^a   Fischer, M ^a   Tannapfel, A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CARCINOID; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GERMANY; HUMAN; HUMAN TISSUE; LATENT PERIOD; LUNG CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MEDICOLEGAL ASPECT; MESOTHELIOMA; OCCUPATIONAL DISEASE; PRIORITY JOURNAL; REVIEW; SMOKING HABIT; ARTICLE; CLASSIFICATION; NOMENCLATURE; PREVALENCE; REGISTER;

CARCINOID TUMOR; GERMANY; HUMANS; LUNG NEOPLASMS; OCCUPATIONAL DISEASES; PREVALENCE; REGISTRIES; TERMINOLOGY AS TOPIC;

EID: 53149132797     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1038173     Document Type: Review

References (28)

1. Crocetti E, Paci E. Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases. Europ J cancer prevent 2003; 12: 191-194
2. Hemminki K, Xinjaun L. Incidence trends and risk factors of carcinoid tumours. Cancer 2001; 92: 2204-2210
3. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumours. Cancer 1997; 79: 813-829
4. Travis W, Corrin B, Shimosato Y et al. WHO - International histological classification of tumours: Histological typing of lung and pleural tumours. Berlin, Heidelberg, New York: Third edition Springer Verlag, 1999
5. Corrin B. Neuroendocrine neoplasm of the lung. Curr diag pathol 1997; 4: 239-250
6. Fink G, Krelbaum T, Yellin A. Pulmonary carcinoid: presentation, diagnosis and outcome in 142 cases in israel and review of 640 cases form the literature. Chest 2001; 119: 1647-1651
7. Travis W, Rush W, Flieder D et al. Survival analysis of 200 pulmonary neuroendocrine tumours with clarification of criteria of atypical carcinoid and its separation from typical carcinoid. Am J surg pathol 1998; 22: 934-944
8. Travis W, Brambilla E, Müller-Hermelink E et al. WHO - classification of tumours - pathology and genetics: Tumours of the lung, pleura, thymus and heart. Vol X WHO Press, 2004
9. Cooper WA, Thourani VH, Gal AA et al. The surgical spectrum of pulmonary neuroendocrine neoplasm's. Chest 2001; 119: 14-18
10. Huang Q, Muzitansky A, Eugene M. Pulmonary neuroendocrine carcinomas: A Review of 234 cases and statistical analysis of 50 cases treated at one institution using a simple clinic pathologic classification. Arch pathol lab med 2002; 126: 545-553
11. Stamatis G, Freitag L, Grechuchna D. Limited and radical resection for tracheal and bronchopulmonary carcinoid tumour. Eur J Cardiothroraci surg 1990; 4: 527-533
12. Campobasso O, Andrion A, Ribotta M et al. The value of the 1981 histological classification in inter observer reproducibility and changing pattern of lung cancer. Int J Cancer 1993; 53: 205-208
13. Lai RS, Hsu HK, Lu JY et al. Cyfra 21-1 enzyme linked immunosorbent assay. Evaluation as a tumour marker in non small cell lung cancer. Chest 1996; 109: 995-1000
14. Feinstein MB, Bach PB. Epidemiology of lung cancer. Chest Surg Clin N Am 2000; 10: 653-661
15. Roggli VL, Sanders LS. Asbestos content of lung tissue and carcinoma of the lung: a clinic pathologic correlation and mineral fibre analysis of 234 cases. Ann occup Hyg 2000; 44: 109-117
16. Godwin JD. Carcinoid tumours: An analysis of 2837 cases. Cancer 1975; 36: 560-569
17. Kraus T, Kirchner T, Raithel H et al. Primäre Karzinoide der Lunge - Asbeststaub-induzierte Malignome i.S. der Bk-Nr. 4104 BeKV? Arbeitsmed Sozialmed Präventivmed 1994; 29: 490-492
18. Berufskrankheitenverordnung: §9 des siebten Buches Sozialgesetzbuch - Gesetzliche Unfallversicherung 2002
19. Brockmann M. Forschungsbericht Pleuramesotheliom: Malignes diffuses Pleuramesotheliom - Heterogenität. Differentialdiagnose und Histogenèse. Sankt Augustin: HVGB, 1992
20. Eitner F, Otto H. Zur Dignität von Asbestkörperzä hlungen im Lungengewebe. Arbeitsmed Sozialmed Präventivmed 1984; 19: 1-5
21. Wächli P, Rajower I, Christen B et al. Ferruginous Bodies im Lungenstaub als Indikatoren für Asbestschäden. Pathologe 1987; 8: 346-350
22. Cote M, Wenzlaff A, Philip P et al. Secondary cancers after lung carcinoid primary: A population based analysis. Lung cancer 2006; 52: 273-279
23. Fisseler-Eckhoff A, Laberke H, Fischer M et al. Karzinoidtumoren der Lunge und Asbest. Pathologe 1998; 19: 425-429
24. Hillerdal G, Douglas W, Henderson MR. Asbestos, asbestosis, pleural plaques and lung cancer. Scand J work enviro health 1997; 23: 93-103
25. Selikoff IJ, Hammond EC, Seidmann H. Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 1980; 46: 2736-2740
26. Mehrtens G, Perlenbach E. Die Berufskrankheitenverordnung (BeKV) Kommentar. Berlin: Erich Schmidt Verlag, 1977
27. Tannapfel A. Deutsches Mesotheliomregister Jahresbericht 2005. Kompass 2005; 9-10: 1825
28. Tannapfel A. Deutsches Mesotheliomregister Jahresbericht 2006. Kompass 2006